US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Medicus Pharma Ltd.

0.2574

-0.0144-5.30%

Post-market: 0.26940.0120+4.66%18:24 EDT

Volume:826.12K

Turnover:215.07K

Market Cap:16.26M

PE:-0.16

High:0.2750

Open:0.2700

Low:0.2550

Close:0.2718

52wk High:3.05

52wk Low:0.2425

Shares:63.18M

Float Shares:56.90M

Volume Ratio:0.40

T/O Rate:1.45%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.6597

EPS(LYR):-2.7356

ROE:-7446.11%

ROA:-110.67%

PB:-9.22

PE(LYR):-0.09

Loading ...

Overview Company News Filings

Medicus Pharma enters USD 22.86 million secured note deal with Streeterville Capital

Medicus Pharma reports Q1 EPS (31c), consensus (22c)

Medicus Pharma Ltd reports results for the quarter ended December 31 - Earnings Summary

Medicus Pharma Q1 EPS $(0.31) Misses $(0.19) Estimate

Benzinga Earnings

Medicus Pharma Ltd - Q1 2026 Net Loss per Share $0.31

THOMSON REUTERS

Medicus Pharma Reports First Quarter 2026 Financial Results and Provides Corporate Update

Medicus Pharma Q1 FY26 net loss widens 77.22% to $9.04 million

Medicus Pharma Ltd expected to post a loss of 19 cents a share - Earnings Preview

Analysts Are Bullish on Top Healthcare Stocks: Zevra Therapeutics (ZVRA), Medicus Pharma Ltd (MDCX)

Medicus reports positive dose-response in Phase 2 SkinJect trial for basal cell carcinoma

Medicus Pharma Ltd - Announces Positive Dose Response in Phase 2 Sknjct-003 Study for Bcc

THOMSON REUTERS

Medicus Pharma Ltd - D-Mna Shows Favorable Safety Profile With No Drug-Related Serious Adverse Events

THOMSON REUTERS

Medicus Pharma Announces Results from Pre-Specified Expanded Phase 2 SKNJCT-003 Data Analysis Demonstrating Positive Dose-Response

Medicus Pharma CEO meets with lawmakers on Energy & Commerce Committee on Capitol Hill

Balancing Pipeline Potential and Funding Risk: Justifying a Buy Rating on Medicus Despite Extended Timelines

Medicus Pharma Expands ATM Equity Program for Funding

BRIEF-Medicus Pharma Ltd May Offer And Sell Common Shares Up To $50 Million Aggregate Through Agents

Medicus Pharma Ltd - May Offer and Sell Common Shares up to $50 Mln Aggregate Through Agents - SEC Filing

THOMSON REUTERS

Medicus Pharma initiated with a Buy at Roth Capital

Medicus Pharma announces annual general and special shareholder meeting

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/MDCX/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MDCX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MDCX\",,,,,undefined,":{"symbol":"MDCX","market":"US","secType":"STK","nameCN":"Medicus Pharma Ltd.","latestPrice":0.2574,"timestamp":1787601600000,"preClose":0.2718,"halted":0,"volume":826119,"hourTrading":{"tag":"盘后","latestPrice":0.2694,"preClose":0.2574,"latestTime":"18:24 EDT","volume":4069,"amount":1053.5886114,"timestamp":1787610249279,"change":0.012,"changeRate":0.04662,"amplitude":0.052059},"delay":0,"changeRate":-0.052980132450331015,"floatShares":56901000,"shares":63180610,"eps":-1.659689,"marketStatus":"Post-Mkt","change":-0.0144,"latestTime":"08-24 18:27:34 EDT","open":0.27,"high":0.275,"low":0.255,"amount":215066.68199982002,"amplitude":0.073584,"askPrice":0.29,"askSize":6,"bidPrice":0.2564,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.659689,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1787616000000},"marketStatusCode":4,"adr":0,"listingDate":1731560400000,"exchange":"NASDAQ","adjPreClose":0.2718,"preHourTrading":{"tag":"盘前","latestPrice":0.27,"preClose":0.2718,"latestTime":"09:21 EDT","volume":7422,"amount":2017.2405951,"timestamp":1787577687274,"change":-0.0018,"changeRate":-0.006623,"amplitude":0.036792},"postHourTrading":{"tag":"盘后","latestPrice":0.2694,"preClose":0.2574,"latestTime":"18:24 EDT","volume":4069,"amount":1053.5886114,"timestamp":1787610249279,"change":0.012,"changeRate":0.04662,"amplitude":0.052059},"volumeRatio":0.404219},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MDCX\",,,,,undefined,":{"symbol":"MDCX","floatShares":56901000,"roa":"-110.67%","roe":"-7446.11%","lyrEps":-2.735593,"volumeRatio":0.404219,"shares":63180610,"dividePrice":0,"high":0.275,"amplitude":0.073584,"preClose":0.2718,"low":0.255,"week52Low":0.2425,"pbRate":"-9.22","week52High":3.05,"institutionHeld":0,"latestPrice":0.2574,"committee":0.886792,"eps":-1.659689,"divideRate":0,"volume":826119,"delay":0,"ttmEps":-1.659689,"open":0.27,"prevYearClose":1.53,"prevWeekClose":0.2718,"prevMonthClose":0.2752,"prevQuarterClose":0.4463,"fiveDayClose":0.26,"twentyDayClose":0.3182,"sixtyDayClose":0.3293},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MDCX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-12","symbol":"MDCX","fiscalQuarterEnding":"2026/06","expectedEps":-0.14,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786507200000,"reportTimeType":"post","actualEps":-0.21},{"market":"US","date":"2026-05-14","symbol":"MDCX","fiscalQuarterEnding":"2026/03","expectedEps":-0.18,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778731200000,"reportTimeType":"post","actualEps":-0.31},{"market":"US","date":"2026-03-25","symbol":"MDCX","fiscalQuarterEnding":"2025/12","expectedEps":-0.32,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1774411200000,"reportTimeType":"post","actualEps":-0.82},{"date":"2025-11-14","symbol":"MDCX","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1763154000000,"name":null,"time":"Post-Mkt","dateTimestamp":1763096400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MDCX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MDCX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":4,"updateTime":1785297600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MDCX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MDCX","date":"2026-08-21","current":-0.155511,"percent":0.899194,"low":-3.23298,"twenty":-2.211687,"median":-0.793282,"eighty":-0.354379,"high":-0.235266,"avg":-1.122787,"sd":0.953831,"marketCap":17197762},"quantilePoints":[{"date":"2025-08-29","current":-2.084531,"twenty":-2.272139,"median":-2.126221,"eighty":-2.109545,"marketCap":35632532},{"date":"2025-09-05","current":-1.907346,"twenty":-2.205434,"median":-2.115799,"eighty":-2.053263,"marketCap":32603766},{"date":"2025-09-12","current":-2.345097,"twenty":-2.211687,"median":-2.12101,"eighty":-2.053263,"marketCap":40086598},{"date":"2025-09-19","current":-2.532705,"twenty":-2.511859,"median":-2.178335,"eighty":-2.080362,"marketCap":43293526},{"date":"2025-09-26","current":-2.817408,"twenty":-2.759151,"median":-2.287772,"eighty":-2.103292,"marketCap":48160186},{"date":"2025-10-03","current":-3.005474,"twenty":-2.869667,"median":-2.511859,"eighty":-2.115799,"marketCap":51374941},{"date":"2025-10-10","current":-3.005474,"twenty":-2.994879,"median":-2.558762,"eighty":-2.122052,"marketCap":51374941},{"date":"2025-10-17","current":-2.885734,"twenty":-2.976858,"median":-2.720313,"eighty":-2.151236,"marketCap":49328130},{"date":"2025-10-24","current":-2.909682,"twenty":-2.974342,"median":-2.774974,"eighty":-2.174166,"marketCap":49737492},{"date":"2025-10-31","current":-2.957578,"twenty":-2.974342,"median":-2.817408,"eighty":-2.178335,"marketCap":50556216},{"date":"2025-11-07","current":-2.897708,"twenty":-2.962368,"median":-2.809662,"eighty":-2.228364,"marketCap":49532811},{"date":"2025-11-14","current":-2.706124,"twenty":-2.950394,"median":-2.817408,"eighty":-2.292984,"marketCap":46257915},{"date":"2025-11-21","current":-1.28141,"twenty":-2.950394,"median":-2.789942,"eighty":-2.178335,"marketCap":44939453},{"date":"2025-11-28","current":-1.355609,"twenty":-2.936025,"median":-2.763,"eighty":-2.119968,"marketCap":48464116},{"date":"2025-12-05","current":-1.183077,"twenty":-2.916866,"median":-2.742046,"eighty":-2.04284,"marketCap":42295956},{"date":"2025-12-12","current":-1.201563,"twenty":-2.904892,"median":-2.700137,"eighty":-1.376181,"marketCap":42956830},{"date":"2025-12-19","current":-1.022869,"twenty":-2.897708,"median":-2.63428,"eighty":-1.31987,"marketCap":36568379},{"date":"2025-12-26","current":-0.955088,"twenty":-2.897553,"median":-2.584818,"eighty":-1.266827,"marketCap":34145173},{"date":"2026-01-02","current":-1.074791,"twenty":-2.896932,"median":-2.511859,"eighty":-1.220048,"marketCap":38424640},{"date":"2026-01-09","current":-1.095865,"twenty":-2.885734,"median":-2.329463,"eighty":-1.179996,"marketCap":39178064},{"date":"2026-01-16","current":-0.976444,"twenty":-2.885734,"median":-2.178335,"eighty":-1.123965,"marketCap":34908660},{"date":"2026-01-23","current":-0.94132,"twenty":-2.866576,"median":-2.167912,"eighty":-1.101485,"marketCap":33652952},{"date":"2026-01-30","current":-0.878097,"twenty":-2.861786,"median":-2.115799,"eighty":-1.061072,"marketCap":31392680},{"date":"2026-02-06","current":-0.765701,"twenty":-2.861786,"median":-2.074108,"eighty":-1.022014,"marketCap":27374416},{"date":"2026-02-13","current":-0.709738,"twenty":-2.853549,"median":-1.933403,"eighty":-0.974021,"marketCap":25373688},{"date":"2026-02-20","current":-0.786136,"twenty":-2.850483,"median":-1.381324,"eighty":-0.961937,"marketCap":28104981},{"date":"2026-02-27","current":-0.97195,"twenty":-2.849812,"median":-1.344224,"eighty":-0.949581,"marketCap":34747976},{"date":"2026-03-06","current":-0.484474,"twenty":-2.849812,"median":-1.300152,"eighty":-0.949581,"marketCap":17320333},{"date":"2026-03-13","current":-0.412761,"twenty":-2.835443,"median":-1.263181,"eighty":-0.891018,"marketCap":14756541},{"date":"2026-03-20","current":-0.412761,"twenty":-2.825864,"median":-1.220048,"eighty":-0.847322,"marketCap":14756541},{"date":"2026-03-27","current":-0.387698,"twenty":-2.82079,"median":-1.201563,"eighty":-0.836077,"marketCap":18330934},{"date":"2026-04-02","current":-0.349652,"twenty":-2.811211,"median":-1.179996,"eighty":-0.820403,"marketCap":16532085},{"date":"2026-04-10","current":-0.367967,"twenty":-2.792337,"median":-1.125793,"eighty":-0.786136,"marketCap":17398052},{"date":"2026-04-17","current":-0.250001,"twenty":-2.775573,"median":-1.109135,"eighty":-0.744685,"marketCap":11820441},{"date":"2026-04-24","current":-0.276475,"twenty":-2.764797,"median":-1.099378,"eighty":-0.508201,"marketCap":13072156},{"date":"2026-05-01","current":-0.235266,"twenty":-2.75402,"median":-1.088841,"eighty":-0.417566,"marketCap":11123732},{"date":"2026-05-08","current":-0.277717,"twenty":-2.74923,"median":-1.069002,"eighty":-0.412761,"marketCap":13130880},{"date":"2026-05-15","current":-0.393186,"twenty":-2.733353,"median":-1.041354,"eighty":-0.401798,"marketCap":18590424},{"date":"2026-05-22","current":-0.308017,"twenty":-2.714637,"median":-1.024243,"eighty":-0.38811,"marketCap":15777036},{"date":"2026-05-29","current":-0.354651,"twenty":-2.703729,"median":-1.018593,"eighty":-0.376126,"marketCap":18165658},{"date":"2026-06-05","current":-0.402361,"twenty":-2.691755,"median":-0.976444,"eighty":-0.374724,"marketCap":20609444},{"date":"2026-06-12","current":-0.35842,"twenty":-2.672597,"median":-0.968141,"eighty":-0.372398,"marketCap":18358733},{"date":"2026-06-18","current":-0.378775,"twenty":-2.63428,"median":-0.962395,"eighty":-0.367967,"marketCap":19401342},{"date":"2026-06-26","current":-0.492235,"twenty":-2.63428,"median":-0.955088,"eighty":-0.371628,"marketCap":25212882},{"date":"2026-07-02","current":-0.442458,"twenty":-2.59471,"median":-0.94132,"eighty":-0.37203,"marketCap":22663265},{"date":"2026-07-10","current":-0.467347,"twenty":-2.543128,"median":-0.915037,"eighty":-0.3732,"marketCap":23938074},{"date":"2026-07-17","current":-0.449095,"twenty":-2.516028,"median":-0.871896,"eighty":-0.374395,"marketCap":23003214},{"date":"2026-07-24","current":-0.424981,"twenty":-2.511859,"median":-0.846653,"eighty":-0.374627,"marketCap":21768066},{"date":"2026-07-31","current":-0.290474,"twenty":-2.411802,"median":-0.843141,"eighty":-0.371929,"marketCap":14878433},{"date":"2026-08-07","current":-0.34025,"twenty":-2.326336,"median":-0.835949,"eighty":-0.363051,"marketCap":17428051},{"date":"2026-08-14","current":-0.353971,"twenty":-2.282561,"median":-0.821824,"eighty":-0.360424,"marketCap":20056990},{"date":"2026-08-21","current":-0.30351,"twenty":-2.211687,"median":-0.793282,"eighty":-0.354379,"marketCap":17197762}],"updateTime":1787590071951},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MDCX\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2638856639","title":"Medicus Pharma enters USD 22.86 million secured note deal with Streeterville Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2638856639","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638856639?lang=en_us&edition=fundamental","pubTime":"2026-05-28 04:45","pubTimestamp":1779914735,"startTime":"0","endTime":"0","summary":"Medicus Pharma closed a note purchase agreement with Streeterville Capital for two secured promissory notes totaling USD 22.86 million.Streeterville funded USD 12 million at closing; another USD 10 million was placed in a controlled deposit account at Lakeside Bank.Secured Promissory Note A-1 carries 8.75% interest, an USD 834,225 original issue discount; matures 18 months from issuance.Secured Promissory Note B carries 5% interest; no original issue discount; matures 18 months from issuance.About USD 2.5 million repaid and extinguished a YA II PN debenture; proceeds earmarked for clinical development, business development, general corporate uses.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medicus Pharma Ltd. published the original","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nNDL1shSs3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MDCX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635643724","title":"Medicus Pharma reports Q1 EPS (31c), consensus (22c)","url":"https://stock-news.laohu8.com/highlight/detail?id=2635643724","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635643724?lang=en_us&edition=fundamental","pubTime":"2026-05-15 06:18","pubTimestamp":1778797121,"startTime":"0","endTime":"0","summary":"“During the first quarter of 2026, Medicus continued to execute on its transformation into a diversified clinical-stage biotechnology company, high...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/medicus-pharma-reports-q1-eps-31c-consensus-22c-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/medicus-pharma-reports-q1-eps-31c-consensus-22c-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MDCX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635729315","title":"Medicus Pharma Ltd reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2635729315","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635729315?lang=en_us&edition=fundamental","pubTime":"2026-05-15 05:00","pubTimestamp":1778792454,"startTime":"0","endTime":"0","summary":"Medicus Pharma Ltd reports results for the quarter ended December 31 - Earnings SummaryMedicus Pharma Ltd MDCX.OQ reported a quarterly adjusted loss of 31 cents per share for the quarter ended Decembe","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nL8N41R2JD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDCX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635726585","title":"Medicus Pharma Q1 EPS $(0.31) Misses $(0.19) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2635726585","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635726585?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:34","pubTimestamp":1778790882,"startTime":"0","endTime":"0","summary":"Medicus Pharma (NASDAQ:MDCX) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0.19) by 63.16 percent. This is a 26.19 percent increase over losses of $(0.42) per share from","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52582192/medicus-pharma-q1-eps-0-31-misses-0-19-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Medicus Pharma Q1 EPS $(0.31) Misses $(0.19) Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDCX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635726743","title":"Medicus Pharma Ltd - Q1 2026 Net Loss per Share $0.31","url":"https://stock-news.laohu8.com/highlight/detail?id=2635726743","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635726743?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:30","pubTimestamp":1778790601,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nTUA8M1DKT:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MDCX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635772644","title":"Medicus Pharma Reports First Quarter 2026 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2635772644","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635772644?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:30","pubTimestamp":1778790600,"startTime":"0","endTime":"0","summary":"Company Advances SkinJect and Teverelix Clinical Programs While Strengthening Financing Flexibility and Expanding Strategic Development InitiativesPHILADELPHIA, May  14, 2026  (GLOBE NEWSWIRE) -- Medi","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/14/3295423/0/en/Medicus-Pharma-Reports-First-Quarter-2026-Financial-Results-and-Provides-Corporate-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MNA","BK4023","BK4588","BCC","LABU","LU1169590202.USD","MDCX","BK4139","BK4567","PD","LU1169589451.USD","BK4104","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635237397","title":"Medicus Pharma Q1 FY26 net loss widens 77.22% to $9.04 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2635237397","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635237397?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:12","pubTimestamp":1778789556,"startTime":"0","endTime":"0","summary":"Medicus Pharma posted a net loss of USD 9.04 million for the quarter ended March 31, 2026, widening from the prior-year period; loss per share narrowed to USD 0.31.Operating loss widened to USD 8.6 million as total operating expenses climbed 67.7% to USD 8.6 million.General and administrative expense rose 88.9% to USD 5.89 million, while R&D increased 34.8% to USD 2.7 million.Phase 2 SKNJCT-003 SkinJect dataset showed 73% clinical clearance in the 200-g cohort at Day 57, with FDA “study may proceed” clearance received to start a Phase 2b dose-optimization study of Teverelix in advanced prostate cancer.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medicus Pharma Ltd. published the original content used to generate this news brief via ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nNDL1mMtjl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDCX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634467553","title":"Medicus Pharma Ltd  expected to post a loss of 19 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2634467553","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634467553?lang=en_us&edition=fundamental","pubTime":"2026-05-09 05:02","pubTimestamp":1778274128,"startTime":"0","endTime":"0","summary":"Medicus Pharma Ltd  expected to post a loss of19cents a share - Earnings Preview Medicus Pharma Ltd MDCX.OQ MDCX.O is expected to  show no change in quarterly revenue when it reports  results on May 1","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nL8N41L2N1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDCX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633017877","title":"Analysts Are Bullish on Top Healthcare Stocks: Zevra Therapeutics (ZVRA), Medicus Pharma Ltd (MDCX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2633017877","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633017877?lang=en_us&edition=fundamental","pubTime":"2026-05-08 02:50","pubTimestamp":1778179812,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Zevra Therapeutics (ZVRA), Medicus Pharma Ltd (MDCX)...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-zevra-therapeutics-zvra-medicus-pharma-ltd-mdcx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-zevra-therapeutics-zvra-medicus-pharma-ltd-mdcx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BLSG","BLSX","LABU","LU0029874061.USD","LU0128526141.USD","BK4139","BK4585","XBI","MDCX","BK4007","BK4581","BK4588","ZVRA","BK4137","BK4112"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633187782","title":"Medicus reports positive dose-response in Phase 2 SkinJect trial for basal cell carcinoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2633187782","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633187782?lang=en_us&edition=fundamental","pubTime":"2026-05-06 19:32","pubTimestamp":1778067154,"startTime":"0","endTime":"0","summary":"Medicus Pharma reported results from a pre-specified expanded Phase 2 analysis of SKNJCT-003 testing its doxorubicin microneedle array for nodular basal cell carcinoma, adding to previously disclosed topline data from broader randomized enrollment.Updated review showed a clearer dose-response signal, with higher-dose treatment delivering the strongest overall clearance pattern versus device-only control.Separation versus control strengthened over follow-up, supporting a drug-driven effect rather than a short-lived device response.Safety profile remained favorable, with no drug-related serious adverse events reported and no signs of systemic doxorubicin toxicity.Dataset is being positioned to support end-of-Phase 2 talks with FDA on a registration path, including selection of dose and target patient population.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nNDL10vV0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","IE00BN0W2T93.GBP","BK4585","IE00B3QW5Z07.USD","IE00BKPKM429.USD","IE00B64PRP62.GBP","SG9999014013.SGD","NDAQ","SG9999014005.SGD","LU0314104364.USD","LU2095319765.USD","SG9999014039.USD","IE00BN0W2V16.EUR","BK4112","SG9999014021.USD","LU2210150020.SGD","BK4588","IE00BN0W2W23.USD","BK4139","MDCX","IE00BGHQF748.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633187796","title":"Medicus Pharma Ltd - Announces Positive Dose Response in Phase 2 Sknjct-003 Study for Bcc","url":"https://stock-news.laohu8.com/highlight/detail?id=2633187796","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633187796?lang=en_us&edition=fundamental","pubTime":"2026-05-06 19:30","pubTimestamp":1778067050,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nFWN41J05G:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MDCX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633187791","title":"Medicus Pharma Ltd - D-Mna Shows Favorable Safety Profile With No Drug-Related Serious Adverse Events","url":"https://stock-news.laohu8.com/highlight/detail?id=2633187791","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633187791?lang=en_us&edition=fundamental","pubTime":"2026-05-06 19:30","pubTimestamp":1778067050,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nFWN41J05G:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MDCX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633180180","title":"Medicus Pharma Announces Results from Pre-Specified Expanded Phase 2 SKNJCT-003 Data Analysis Demonstrating Positive Dose-Response","url":"https://stock-news.laohu8.com/highlight/detail?id=2633180180","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633180180?lang=en_us&edition=fundamental","pubTime":"2026-05-06 19:30","pubTimestamp":1778067000,"startTime":"0","endTime":"0","summary":"200g Cohort Achieves 55% Complete Response at Day 57 Emerging as Registrational Grade Lead RegimenPHILADELPHIA, May  06, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) (\"Medicus\" or the \"","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/06/3288692/0/en/Medicus-Pharma-Announces-Results-from-Pre-Specified-Expanded-Phase-2-SKNJCT-003-Data-Analysis-Demonstrating-Positive-Dose-Response.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDCX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630395692","title":"Medicus Pharma CEO meets with lawmakers on Energy & Commerce Committee on Capitol Hill","url":"https://stock-news.laohu8.com/highlight/detail?id=2630395692","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630395692?lang=en_us&edition=fundamental","pubTime":"2026-04-27 19:30","pubTimestamp":1777289400,"startTime":"0","endTime":"0","summary":"Builds Support for Accelerated Access to SkinJect for Gorlin Syndrome patients with a Rare Autosomal Dominant DiseasePHILADELPHIA, April  27, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/27/3281511/0/en/Medicus-Pharma-CEO-meets-with-lawmakers-on-Energy-Commerce-Committee-on-Capitol-Hill.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1169590202.USD","LU1169589451.USD","MNA","BK4567","MDCX","BK4139","IND","BCC","BK4023","PD","BK4104"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630679803","title":"Balancing Pipeline Potential and Funding Risk: Justifying a Buy Rating on Medicus Despite Extended Timelines","url":"https://stock-news.laohu8.com/highlight/detail?id=2630679803","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630679803?lang=en_us&edition=fundamental","pubTime":"2026-04-25 20:15","pubTimestamp":1777119332,"startTime":"0","endTime":"0","summary":"Jason McCarthy, an analyst from Maxim Group, maintained the Buy rating on Medicus Pharma Ltd. The associated price target was lowered to $2.00. Jas...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/balancing-pipeline-potential-and-funding-risk-justifying-a-buy-rating-on-medicus-despite-extended-timelines-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/balancing-pipeline-potential-and-funding-risk-justifying-a-buy-rating-on-medicus-despite-extended-timelines-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MDCX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630487806","title":"Medicus Pharma Expands ATM Equity Program for Funding","url":"https://stock-news.laohu8.com/highlight/detail?id=2630487806","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630487806?lang=en_us&edition=fundamental","pubTime":"2026-04-25 06:21","pubTimestamp":1777069305,"startTime":"0","endTime":"0","summary":"Medicus Pharma Ltd ( ($MDCX) ) has provided an announcement. On April 23, 2026, Medicus Pharma Ltd. amended its equity distribution arrangement wit...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/medicus-pharma-expands-atm-equity-program-for-funding?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/medicus-pharma-expands-atm-equity-program-for-funding?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4215","BK4585","BK4588","EQR","MDCX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629869263","title":"BRIEF-Medicus Pharma Ltd May Offer And Sell Common Shares Up To $50 Million Aggregate Through Agents","url":"https://stock-news.laohu8.com/highlight/detail?id=2629869263","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629869263?lang=en_us&edition=fundamental","pubTime":"2026-04-24 06:06","pubTimestamp":1776981998,"startTime":"0","endTime":"0","summary":"BRIEF-Medicus Pharma Ltd May Offer And Sell Common Shares Up To $50 Million Aggregate Through Agents April 23  - Medicus Pharma Ltd MDCX.O:MEDICUS PHARMA LTD - MAY OFFER AND SELL COMMON SHARES UP TO $50 MILLION AGGREGATE THROUGH AGENTS - SEC FILINGSource text: [ID:n0001062993-26-002127]Further company coverage: MDCX.O ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260423:nFWN41616T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MDCX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629866189","title":"Medicus Pharma Ltd - May Offer and Sell Common Shares up to $50 Mln Aggregate Through Agents - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2629866189","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629866189?lang=en_us&edition=fundamental","pubTime":"2026-04-24 05:12","pubTimestamp":1776978747,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260423:nFWN41616T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MDCX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629364550","title":"Medicus Pharma initiated with a Buy at Roth Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2629364550","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629364550?lang=en_us&edition=fundamental","pubTime":"2026-04-21 19:53","pubTimestamp":1776772435,"startTime":"0","endTime":"0","summary":"Roth Capital initiated coverage of Medicus Pharma (MDCX) with a Buy rating and $9 price target The firm projects growing revenue from the company’s...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/medicus-pharma-initiated-with-a-buy-at-roth-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/medicus-pharma-initiated-with-a-buy-at-roth-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MDCX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629808737","title":"Medicus Pharma announces annual general and special shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2629808737","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629808737?lang=en_us&edition=fundamental","pubTime":"2026-04-21 18:05","pubTimestamp":1776765913,"startTime":"0","endTime":"0","summary":"Medicus Pharma set annual general and special shareholder meeting for June 3, 2026 in Toronto, Ontario.Shareholders will vote on appointment of KPMG as auditor, including authorization to set auditor remuneration.Ballot includes election of nine director nominees for the coming year.Special resolution seeks authority for board to consolidate common shares at a ratio up to 50-to-1.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medicus Pharma Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 21, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260421:nNDL7fv5BX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MDCX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":3,"totalSize":106,"code":"91000000","status":"200"}]}}